HomeAI · summaries
Storia in 3 fonti
Why Semaglutide is an inflection point for India’s generics sector?
Discover how the Semaglutide episode could reshape India's generics sector, revealing vulnerabilities and opportunities for future growth.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Adoption of generic semaglutide depends on the delivery device
The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.
- ·
thehindu.com
Why Semaglutide is an inflection point for India’s generics sector?
Discover how the Semaglutide episode could reshape India's generics sector, revealing vulnerabilities and opportunities for future growth.
- ·
businessday.co.za
India’s Sun Pharma wins South Africa approval to launch generic Ozempic
South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection